Featuring a summary of the updated ICMJE recommendations, the failure of the FDA and the NIH to enforce clinical trial reporting laws, an independent report aiming to improve the transparency of open access services, and the new article format coming to PLOS ONE
Featuring the current predictions for publishing trends in 2020, draft guidance on how to implement the DORA principles in research organizations and a new international observatory to tackle predatory publishers
Featuring Altmetric’s Christmas list, the current status of transformative agreements in relation to Plan S and a review of the ICMJE’s data sharing policy.
Featuring persistent object identifiers for research organizations, an investigation into the standards of reporting randomized clinical trials, the co-production of scientific research and the development of the next set of Good Publication Practice guidelines.
Featuring the new read-and-publish deal between Elsevier and Carnegie Mellon University, a beta repository for research from UK cultural and heritage organizations and the range of APC across publishers
Featuring highlights from the ISMPP U webinar on plain-language summaries, lessons learned from the YODA Project and the benefits of Wiley’s ‘Under Review’ service.
Featuring the proposed concept of geowalling, highlights from World Science Day 2019, the Health Research Authority’s trip to the House of Commons and ISMPP’s support of the Open Pharma position statement.
Featuring the return of ‘Unreported clinical trial of the week’, exciting opportunities in the age of digital publishing and a new pilot to make comments on preprints publicly available
Featuring a sneak preview of responses to the Health Research Authority ‘Make it Public’ consultation, an investigation into researchers’ communication with study participants and the worldwide spread of endorsements for the Open Pharma position statement on open access
Featuring the launch of the Open Pharma position statement on open access, an introduction to the Open Science in Action Inaugural Symposium and a call to action for the UK government to do more to ensure transparent clinical trial reporting.